HDAC6 and myocardial infarction: This study is apparently the first to report the beneficial action of HDAC6 inhibition on remodeling remote from the infarct area, suggesting that a selective HDAC6 inhibitor might have potential utility in the management of atrial fibrosis and remodeling in patients with MI.